Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FTDZX vs. IBB: which is better?

Bottom line

FTDZX vs IBB: the short answer

FTDZX (Franklin Biotechnology Discovery Fund) and IBB (iShares Biotechnology ETF) are both mutual funds.

But IBB is far broader, holding 254 positions to 126 for FTDZX, so beyond the top names it adds exposure FTDZX doesn't have.

IBB is cheaper at 0.44% vs 0.76% — a difference of $32 a year per $10,000 invested.

Over five years, FTDZX returned +6.4% a year vs +2.5% for IBB.

Updated Nov 19, 2026

FTDZX vs IBB side by side

FTDZXIBB
TypeMutual fundETF
Fund familyFranklin TempletoniShares
CategoryTechnology SectorTechnology Sector
Expense ratio0.76%0.44%
Annual cost per $10k$76$44
10-yr cost on $10k (prospectus)$954$555
Max front load0%None
12b-1 fee0%0%
1-yr return+52.7%+28.0%
5-yr return (annualized)+6.4%+2.5%
10-yr return (annualized)+7.2%+4.4%
Best quarter—+26.8%
Worst quarter—−22.9%
Net assets (fund)$1.2B$5.9B
Number of holdings126254
Portfolio turnover38%27%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

7 of FTDZX's top 25 holdings also appear in IBB's top 25.

Shared top holdings
HoldingFTDZXIBB
Amgen, Inc.4.39%7.50%
Gilead Sciences, Inc.3.86%7.52%
Regeneron Pharmaceuticals, Inc.3.77%5.70%
Argenx SE3.62%3.15%
Vertex Pharmaceuticals, Inc.3.54%7.66%
Insmed, Inc.1.99%2.95%
Neurocrine Biosciences, Inc.1.82%1.34%

Source: SEC Form N-PORT

FTDZX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

FAQ

What is the difference between FTDZX and IBB?
FTDZX (Franklin Biotechnology Discovery Fund) and IBB (iShares Biotechnology ETF) are both mutual funds. But IBB is far broader, holding 254 positions to 126 for FTDZX, so beyond the top names it adds exposure FTDZX doesn't have.
Which is cheaper, FTDZX or IBB?
IBB has the lower expense ratio (0.44%).
Should I own both FTDZX and IBB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.